Navigation Links
Biomedtex Inc. Announces Direction of Initial Product Line
Date:10/25/2007

BOCA RATON, Fla., Oct. 25 /PRNewswire-FirstCall/ -- Biomedtex Inc. (Pink Sheets: BMDX.PK) ("Biomed" or "the Company")

Biomedtex is pleased to announce the company's initial direction for its first line of health-conscious products manufactured entirely in the United States. The product line will consist of several high-end specialty lines of flavored and unflavored waters utilizing various pure natural elements, silver being the first, while maintaining a price point consistent with current specialty waters already on the consumer market.

Additionally, successful talks have been continuing with an international award-winning natural spring water company with the focus of using their product as the base water ingredient in the product line. Biomedtex is also aggressively pursuing a potential candidate for a joint venture looking to increase its market share in an accelerated manner.

"I am very excited about the direction of our company to date and looking forward to our positive expansion," said A. Marc Rocca, President COE COB, Biomedtex Inc.

A. Marc Rocca

President COE COB

Biomedtex Inc.

917-526-6700

About Biomedtex Inc.

The Company's mission is to identify, evaluate and assess a broad spectrum of global medical technologies, and healthcare solutions, and then seek to capture and promote innovations with significant commercial and beneficial potential. Biomedtex is a biomedical research company exploring centuries old medical benefits of natural elements. Biomedtex will examine the potential of these benefits by bringing these alternative medical solutions to the mass market through FDA approval.

Safe Harbor Statement: This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward-looking statements, particularly those risks and uncertainties inherent in the process of developing start-up companies. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. Biomedtex Inc. disclaims any intent or obligation to update those forward-looking statements, except as otherwise specifically stated.

http://www.biomedtex.com


'/>"/>
SOURCE Biomedtex Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2017)... ... September 17, 2017 , ... ... South Korean Ministry of Food and Drug Safety (KMFDS) for an Investigational New ... the Middle East Respiratory Syndrome coronavirus (MERS-CoV). The study in Korea represents the ...
(Date:9/14/2017)... Lafayette, Ind (PRWEB) , ... ... ... of AMRI’s Global Analytical Services, formally introduces its flexible scientist program (FSP)-- ... offers volume-based, preferred-rate pricing. The FSP, which combines SSCI’s extensive project-based analytical ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... portfolio, clinically-relevant starting and ancillary materials that generate unprecedented efficiencies in adult ... therapies. The CliniControl product portfolio will radically simplify major steps in product ...
(Date:9/14/2017)... ... 2017 , ... AxioMed is pleased to announce the success ... completed the procedure on a 35-year-old female patient suffering from degenerative disc disease ... L5-S1. The patient failed conservative treatments prior to undergoing surgery. , Dr. Yang ...
Breaking Biology Technology:
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):